Max

260 posts

Max banner
Max

Max

@MaxKrummel

Prof @ucsf @immunox, Immunologist,Immunotherapy pioneer,believer in the power of curiosity,striving to make sense of complicated things, typically enthusiastic.

San Francisco, CA Katılım Ağustos 2017
59 Takip Edilen2.9K Takipçiler
Max
Max@MaxKrummel·
Interested in the evolution of how we share and curate our science? For those coming to CICON24, check out @beiyun_liu and this poster. For those not there, try this out, participate, enjoy helping science and your colleagues move forward: solvingfor.org/campaigns-data…
Max tweet media
English
0
7
14
4.1K
Max
Max@MaxKrummel·
@MReinaCampos Haha! After years of looking for it, it happened with you! Thanks for the photos—I will now be your official witness! I am converted.
English
0
0
0
309
Max retweetledi
Miriam Merad, MD, PhD
Miriam Merad, MD, PhD@MiriamMerad·
Looking forward to welcoming everyone to beautiful Killarney for #KSMyeloidTargets24 with co-organizer @MaxKrummel, and discussing how academia & industry can align their efforts to develop effective myeloid cell targeted therapies for cancer.
English
0
15
93
10.9K
Max
Max@MaxKrummel·
Very excited about this. Richard and I have a chance to share some pretty cool options to unleash science. Come check it out and try it out. Feels more like what we all came into science for… and a good product of all your collective minds.
Campbell 🍅🥫@lofiMRI

Curious about academic publishing's future? Looking for open-access alternatives? Upcoming seminar at UPenn w/ @cshperspectives of @biorxivpreprint & @medrxivpreprint and @MaxKrummel from @SolvingForSci should be illuminating!💡 🕤3/20 10:30-11:30AM 📍CRB, Austrian Auditorium

English
0
3
11
10.5K
Max
Max@MaxKrummel·
I tried this out last week. It already feels much better as a reviewer when you are writing directly to the author and towards genuinely improving the quality of the science. It also is cognitively easier (and faster) to do a better job. This is going to be good.
Solving For Science@SolvingForSci

Immunologists, are you stuck in peer review purgatory? 🕙 Or perhaps you're closing out the year with a new preprint! We've got the pilot for you! Sign up to share your preprint, and let's fix publishing together! solvingfor.org/dsdc-pilot

English
0
3
18
5.1K
Max retweetledi
UCSF Bakar ImmunoX Initiative
UCSF Bakar ImmunoX Initiative@immunox·
We are grateful to @FounderyInc. for their generosity and support of four ImmunoX fellows and for leading the charge in developing an innovative way to support the education of future scientists and ensure diversity, equity, and inclusion in science. #TheFutureisBright
English
0
1
2
1.5K
Max retweetledi
Solving For Science
Solving For Science@SolvingForSci·
‼️🚨Kick off your weekend with an intro to a new, journal-free system for publishing—developed by and for scientists—that we’re piloting with our friends in immunology. Feeling intrigued? fed-up? skeptical? rebellious? Come watch the pitch! 😎 zoom.us/meeting/regist…
Solving For Science tweet media
English
0
9
17
5.4K
Max
Max@MaxKrummel·
@MartinGuilliams Thanks Martin! I hope it helps us all get more specific with our myeloid biology. Thank You and your colleagues again for hosting such a fantastic and energetic meeting in charming Ghent.
English
0
0
3
331
Martin Guilliams
Martin Guilliams@MartinGuilliams·
⁦To close this fantastic #EMDS2023 meeting we have a beautiful talk from Max Krummel ⁦@MaxKrummel⁩ 🤩🤩🤩, who will kill the outdated M1/M2 concept. The whole fields thanks you for this Max 🙏🏼🙏🏼🙏🏼🙏🏼
Martin Guilliams tweet media
English
2
4
68
4.2K
Max
Max@MaxKrummel·
@ad1600 @RayArja You helped us get started on this, Adil. Forever appreciative.
English
0
0
1
139
Max
Max@MaxKrummel·
Ten years ago, Miranda Broz first described rare CD103+ intratumoral DC (now:TucDC1) and their role in driving T cell responses. Here, @RayArja in the lab found the ID/signature of also-rare T cells that have exceptional effector responses. tinyurl.com/StarEffectors Formative.
English
3
11
77
11.9K
Max
Max@MaxKrummel·
@FounderyInc Beyond the science team and these investors and advisors, we could never have done this without the wisdom and support of @PeteBriger , the partnership of our @UCSF, @ImmunoX communities, and an emerging quiver of cool and actionable targets in the powerful immune system.
English
0
0
1
362
Max
Max@MaxKrummel·
An anchoring aspect of this work is that tumors get their immune archetypes from one of the many normal functions of the immune system. Tumor immunity is no longer simply about 'immunity' v. tolerance. Join the team to build on this understanding, build it up, knock it down.
Max tweet media
Alexis Combes@alexis_combes

🎉Our Cancer immune archetype perspective is on @NatureRevCancer's July cover!. We're seeking a #postdoc to unravel the cellular networks and gene programs behind these archetypes. If you're fueled by passion for immunology and oncology 👉t.ly/0C3bB Please RT🙏

English
0
5
29
5.8K
Max
Max@MaxKrummel·
There are higher risks associated with development of new ideas. Foundery Immune Studios provides crucial preclinical infrastructure+capital to bolster confidence in the therapeutic potential of novel ideas and develop them into first-in-class drugs. I was happy to share the idea
English
0
1
3
919
Max
Max@MaxKrummel·
In my experience, the most revolutionary scientific concepts face a high degree of skepticism from the venture community as they are supported by a limited number of experiments. Trapped in the 'therapeutic valley of death,' these ideas typically lie fallow in academia. 1/2
English
1
1
12
4.5K

Keşfet

@beiyun_liu @MReinaCampos @SEinmunologia @SCImmunologia @EuMacDcSoc @miltenyibiotec @inmunotek @BioLegend